Healthcare & Medical Devices Global On demand · 24-48h

Global Exhaled NO Detector Market Strategic Research Report

Global Exhaled NO Detector Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Exhaled NO Detector Market
$1232025
15.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Desktop, Handheld

By Application: Children, Adults

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: NIOX Group (Circassia AB), CAIRE (NGK), ECO PHYSICS AG, Bosch Healthcare Solutions, Bedfont Scientific, Sunvou Medical Electronics, e-LinkCare Meditech, Hefei Micro Valley Medical, Guangzhou Ruipu Medical Technology, WinLand Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 91 pages
Market size 2025
$123
Million USD
Forecast CAGR
15.6%
2025-2032
Forecast 2032
$339.3
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Exhaled NO Detector market size is predicted to grow from US$ 123 million in 2025 to US$ 332 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.

The exhaled oxide (NO) betector is a non-invasive medical device that is specifically designed to measure the concentration of nitric oxide in exhaled breath to assess the level of airway inflammation. This technology is essential for the diagnosis and management of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases. By analyzing the FeNO (fractional exhaled nitric oxide) level in exhaled breath, doctors can more accurately understand the patient's airway inflammation status, thereby optimizing treatment options and reducing unnecessary medication use.

Global Exhaled NO Detector key players include NIOX Group (Circassia AB), CAIRE, ECO PHYSICS AG, Bosch Healthcare Solutions and Bedfont Scientific, etc. Global top five manufacturers hold a share over 90%.

The largest market is Europe, has a share over 42%, followed by Asia Pacific and North America, with around 21% and 36% market share respectively.

In terms of product, Desktop type is the largest segment, with a share about 80%. And in terms of application, the largest application is Adults, has a share over 62%, followed by Children.

With the global incidence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) rising, the demand for non-invasive diagnostic tools is increasing, driving the rapid development of this technology. First, the equipment is becoming smarter. Modern FeNO detectors can not only quickly and accurately measure the concentration of nitric oxide in exhaled breath, but also integrate advanced data analysis functions, such as connecting to mobile applications via Bluetooth or Wi-Fi to achieve data cloud synchronization and long-term tracking of personal health records. The new handheld detector is compact and easy to operate, allowing patients to test themselves at home without frequent visits to medical institutions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Exhaled NO Detector market?

What factors are driving Exhaled NO Detector market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Exhaled NO Detector market opportunities vary by end market size?

How does Exhaled NO Detector break out by Type, by Application?

This report presents a comprehensive overview of the global Exhaled NO Detector market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Desktop
  • Handheld

Segment by Application

  • Children
  • Adults

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Exhaled NO Detector market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Children, Adults evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Exhaled NO Detector Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 15.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$123
2025
Forecast
$339.3
2032
CAGR
15.6%
2025–2032
Regions
5
global
Key companies
NIOX Group (Circassia AB)CAIRE (NGK)ECO PHYSICS AGBosch Healthcare SolutionsBedfont ScientificSunvou Medical Electronicse-LinkCare MeditechHefei Micro Valley Medical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
DesktopHandheld
By Application
ChildrenAdults

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Desktop
  • 3.1.3 Handheld
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Children
  • 4.1.3 Adults
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 NIOX Group (Circassia AB)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 CAIRE (NGK)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ECO PHYSICS AG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Bosch Healthcare Solutions
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Bedfont Scientific
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Sunvou Medical Electronics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 e-LinkCare Meditech
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Hefei Micro Valley Medical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Guangzhou Ruipu Medical Technology
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 WinLand Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Exhaled NO Detector market?
The global Exhaled NO Detector market is estimated at US$ 123 million in 2025 (base year) and is projected to reach US$ 332 million by 2032.
What is the forecast CAGR for the Exhaled NO Detector market?
The market is expected to grow at a CAGR of 15.6% from 2026 to 2032, expanding from US$ 123 million in 2025 to US$ 332 million in 2032, roughly 2.7 times its base-year value.
What is Exhaled NO Detector?
The exhaled oxide (NO) betector is a non-invasive medical device that is specifically designed to measure the concentration of nitric oxide in exhaled breath to assess the level of airway inflammation. This technology is essential for the diagnosis and management of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases.
What are the main segments of the Exhaled NO Detector market by type?
By type, the market is segmented into Desktop and Handheld.
Which applications drive demand in the Exhaled NO Detector market?
Key applications covered include Children and Adults.
Who are the key players in the Exhaled NO Detector market?
Key players profiled include NIOX Group (Circassia AB), CAIRE (NGK), ECO PHYSICS AG, Bosch Healthcare Solutions, Bedfont Scientific, Sunvou Medical Electronics, e-LinkCare Meditech and Hefei Micro Valley Medical, among 10 companies covered in total.
Which regions and countries are covered for Exhaled NO Detector?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Exhaled NO Detector market?
With the global incidence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) rising, the demand for non-invasive diagnostic tools is increasing, driving the rapid development of this technology.
Who should buy the Exhaled NO Detector market report?
The report is intended for manufacturers and solution providers, distributors and end users in Children and Adults, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Exhaled NO Detector market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.